• Worst Performing IPOs of the Year - Take Two

    By Shas Dey - December 17, 2012 | Tickers: CERE, ENPH, MPO

    A few days back, in another publication, I reviewed some of the worst performing IPOs of the year. The list contained three major duds: Envivio, Zynga and CafePress. The common string through these IPOs was that they all belonged to the heated up Internet/web segment. Thus, these stocks were not only hyped up but were also fully priced, which limited their upside potential, post-listing. However, the malady of IPO more »

  • What the Bioeconomy Means for Investors

    By Maxxwell A.R. Chatsko - November 27, 2012 | Tickers: AMRS, CERE, LIFE, MON, MYGN, SZYM | Editor's Choice

    On April 1, the White House released the National Bioeconomy Blueprint (opens PDF) that outlined the importance of transitioning health/life science, chemical production, agriculture, and other industries into the 21st century. Yes, it was April Fool’s Day. No, the White House wasn’t joking.

    Despite being lost in the midst of an election year the message was clear: an American bioeconomy can transform the world. The report more »